PacBio (PACB) announced CiFi, a new community-developed method that enables chromosome-scale, haplotype-resolved genome assemblies from a single sequencing run. By integrating chromatin conformation capture with PacBio HiFi long-read sequencing, CiFi delivers multi-contact reads and longer fragments that increase the information content of proximity ligation experiments in a single Revio sequencing run. “CiFi expands our multiomics capabilities, increasing what we can do on HiFi sequencing systems without new hardware and unlocking new customer use cases,” said David Miller, Vice President of Global Marketing at PacBio. “The work from the Megan Dennis Lab at UC Davis shows what becomes possible when innovative chromatin capture methods are paired with the accuracy of HiFi sequencing.”
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PACB:
- Cathie Wood Closes Out 2025 with a Rocket Lab (RKLB) Trim and Fresh Biotech Bets
- Cathie Wood’s Christmas Trades: ARK Invest Bets on WeRide and CRISPR
- Cathie Wood’s ARK Investment buys 333K shares of PacBio today
- Cathie Wood’s ARK Investment buys 799K shares of PacBio today
- PacBio management to meet virtually with Piper Sandler
